{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T04:42:07Z","timestamp":1784522527957,"version":"3.55.0"},"reference-count":34,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1UG1DA04944"],"award-info":[{"award-number":["1UG1DA04944"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","award":["IK2HX003090"],"award-info":[{"award-number":["IK2HX003090"]}],"id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007181","name":"Quality Enhancement Research Initiative","doi-asserted-by":"publisher","award":["PEI 19-001"],"award-info":[{"award-number":["PEI 19-001"]}],"id":[{"id":"10.13039\/100007181","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Clinical pharmacist practitioners (CPPs) play an increasingly important role in interdisciplinary care for patients with substance use disorders (SUDs). However, CPPs\u2019 scope of practice varies substantially across clinics and settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>We sought to describe CPP practices and activities within an interdisciplinary, team-based primary care clinic dedicated to treat Veterans with histories of substance use disorders, experience of homelessness, high medical complexity, and other vulnerabilities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of CPP activities using Department of Veterans Affairs (VA) administrative data in 2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>CPPs provided care for 228 patients, including 766 in-clinic visits, 341 telephone visits, and 626 chart reviews, with an average of 2.5\u2009hours spent per patient per year. Patients seen by CPPs frequently experience mental health conditions and SUDs, including depression (66%), post-traumatic stress disorder (52%), opioid use disorder (OUD) (45%), and alcohol use disorder (44%). CPPs managed buprenorphine medications for OUD or chronic pain in 76 patients (33%). Most CPP interventions (3330 total) were for SUDs (33%), mental health conditions (24%), and pain management (24%), with SUD interventions including medication initiation, dose changes, discontinuations and monitoring. As part of opioid risk mitigation efforts, CPPs queried the state\u2019s prescription drug monitoring program 769 times and ordered 59 naloxone kits and 661 lab panels for empaneled patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>CPPs managed a high volume of vulnerable patients and provided complex care within an interdisciplinary primary care team. Similar CPP roles could be implemented in other primary care settings to increase access to SUD treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/08897077231198679","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:20:00Z","timestamp":1697415600000},"page":"330-336","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":12,"title":["Care Practices of Mental Health Clinical Pharmacist Practitioners Within an Interdisciplinary Primary Care Model for Patients With Substance Use Disorders"],"prefix":"10.1177","volume":"44","author":[{"given":"Annette","family":"Percy","sequence":"first","affiliation":[{"name":"Behavioral Health Interdisciplinary Program, Southern Oregon Rehabilitation Center and Clinics, White City, OR, USA"},{"name":"Vulnerable Veteran Innovative Patient-Aligned Care Team (VIP), VA Salt Lake City Health Care System, Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Taylor","family":"Kelley","sequence":"additional","affiliation":[{"name":"Vulnerable Veteran Innovative Patient-Aligned Care Team (VIP), VA Salt Lake City Health Care System, Salt Lake City, UT, USA"},{"name":"Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Valentino","sequence":"additional","affiliation":[{"name":"Vulnerable Veteran Innovative Patient-Aligned Care Team (VIP), VA Salt Lake City Health Care System, Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Butz","sequence":"additional","affiliation":[{"name":"Vulnerable Veteran Innovative Patient-Aligned Care Team (VIP), VA Salt Lake City Health Care System, Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob D.","family":"Baylis","sequence":"additional","affiliation":[{"name":"Vulnerable Veteran Innovative Patient-Aligned Care Team (VIP), VA Salt Lake City Health Care System, Salt Lake City, UT, USA"},{"name":"Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Suo","sequence":"additional","affiliation":[{"name":"Vulnerable Veteran Innovative Patient-Aligned Care Team (VIP), VA Salt Lake City Health Care System, Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2453-8871","authenticated-orcid":false,"given":"Adam J.","family":"Gordon","sequence":"additional","affiliation":[{"name":"Vulnerable Veteran Innovative Patient-Aligned Care Team (VIP), VA Salt Lake City Health Care System, Salt Lake City, UT, USA"},{"name":"Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1533-7469","authenticated-orcid":false,"given":"Audrey L.","family":"Jones","sequence":"additional","affiliation":[{"name":"Vulnerable Veteran Innovative Patient-Aligned Care Team (VIP), VA Salt Lake City Health Care System, Salt Lake City, UT, USA"},{"name":"Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,10,15]]},"reference":[{"key":"bibr1-08897077231198679","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.05.048"},{"key":"bibr2-08897077231198679","unstructured":"Department of Veterans Affairs and Department of Defense Management of Substance Use Disorders Work Group. VA\/DoD Clinical Practice Guidelines for the Management of Substance Use Disorders, version 4.0. 2021. Accessed online Sep 21, 2023. https:\/\/www.healthquality.va.gov\/guidelines\/MH\/sud\/VADoDSUDCPG.pdf"},{"key":"bibr3-08897077231198679","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107732"},{"key":"bibr4-08897077231198679","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.18m12532"},{"key":"bibr5-08897077231198679","author":"Park-Lee E","journal-title":"CBHSQ Data Review"},{"key":"bibr6-08897077231198679","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2022.1.53834"},{"key":"bibr7-08897077231198679","unstructured":"Ahmad F, Rossen L, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics. Accessed Mar 7, 2022. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm"},{"key":"bibr8-08897077231198679","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000717"},{"key":"bibr9-08897077231198679","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13027"},{"key":"bibr10-08897077231198679","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-021-07355-7"},{"key":"bibr11-08897077231198679","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-019-0151-7"},{"key":"bibr12-08897077231198679","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-017-4202-z"},{"key":"bibr13-08897077231198679","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2016.07.011"},{"key":"bibr14-08897077231198679","volume-title":"Evidence Brief: Barriers and Facilitators to Use of Medications for Opioid Use Disorder","author":"Mackey K","year":"2019"},{"key":"bibr15-08897077231198679","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13260"},{"key":"bibr16-08897077231198679","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-021-00263-5"},{"key":"bibr17-08897077231198679","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000786"},{"key":"bibr18-08897077231198679","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-022-07975-7"},{"key":"bibr19-08897077231198679","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp19X705461"},{"key":"bibr20-08897077231198679","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxab003"},{"key":"bibr21-08897077231198679","unstructured":"American Pharmacists Association. APhA scope of practice. Accessed June 13, 2022. https:\/\/www.pharmacist.com\/Practice\/Practice-Resources\/Scope-of-Practice"},{"key":"bibr22-08897077231198679","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.n183353"},{"key":"bibr23-08897077231198679","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxaa405"},{"key":"bibr24-08897077231198679","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2018.1449172"},{"key":"bibr25-08897077231198679","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2015.14177"},{"key":"bibr26-08897077231198679","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2020.1832507"},{"key":"bibr27-08897077231198679","unstructured":"Pharmacy Benefits Management Clinical Pharmacy Practice Office. Clinical pharmacist practitioner (CPP) role in substance use disorders (SUD). United States Department of Veterans Affairs; 2020. Accessed online Sep 9, 2023. https:\/\/www.pbm.va.gov\/PBM\/CPPO\/Documents\/ExternalFactSheet_CPPRoleinSubstanceUseDisorders_508.pdf"},{"key":"bibr28-08897077231198679","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2020.1787299"},{"key":"bibr29-08897077231198679","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2019.07.269"},{"key":"bibr30-08897077231198679","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-022-07456-x"},{"key":"bibr31-08897077231198679","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp170186"},{"key":"bibr32-08897077231198679","doi-asserted-by":"publisher","DOI":"10.4212\/cjhp.v73i2.2982"},{"key":"bibr33-08897077231198679","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2014.0204"},{"issue":"7","key":"bibr34-08897077231198679","volume":"19","author":"Rosland AM","year":"2013","journal-title":"Am J Manag Care"}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08897077231198679","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/08897077231198679","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08897077231198679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:40:24Z","timestamp":1777668024000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/08897077231198679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1177\/08897077231198679"],"URL":"https:\/\/doi.org\/10.1177\/08897077231198679","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}